Research and Markets: Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018

Research and Markets (http://www.researchandmarkets.com/research/25g3fx/research_report) has announced the addition of the "Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2014-2018" report to their offering.

China is the world's largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.

The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets and pork prices and significant decrease in output volume of pork. In May 2007, the Ministry of Agriculture of China approved the production of highly- pathogenic porcine reproductive and respiratory syndrome inactivated vaccine (NVDC- JXA1) in six manufacturers of biological products. Porcine reproductive and respiratory syndrome (PRRS) remains one of the key compulsory immunity diseases in China.

The market competition is intensive in the PRRS vaccine industry in China. There are 26 manufacturers of PRRS vaccines in China, including Dahuanong, Xinjiang Tecon Animal Husbandry Bio- Technology Co., Ltd., Qingdao Yebio Bioengineering Co., Ltd. and Inner Mongolia Jinyu Group Stock Company. In terms of the direct sales of high- end vaccines, the PRRS vaccines of Zoetis went to the market in Guangzhou at the end of August 2013 after Boehringer. These foreign- funded vaccine brands occupy the market shares using the brand advantages, which intensify the market competition.

Key Topics Covered:

1 Status of Global and China PRRS Vaccine Market

2 Factors Influencing Development of PRRS Vaccines in China, 2009-2013

3 Operation Status of PRRS Vaccine Industry in China, 2009-2013

4 Major Manufacturers of PRRS Vaccines in China, 2011-2013

5 Status of PRRS Vaccine Purchase in Some Local Governments in China, 2013

6 Prospect of China PRRS Vaccine Industry, 2014-2018

Companies Mentioned

- Guangdong Dahuanong Animal Health Products Co., Ltd

- Inner Mongolia Jinyu Group Stock Company

- Qingdao Yebio Bioengineering Co., Ltd.

- Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/25g3fx/research_report